ProBioGen AG, a specialist in mammalian cell engineering and cell culture, has reorganised its business development team. Effective immediately, Klaus Stünkel, formerly a consultant and executive with Bayer Pharma, has been appointed Vice President Business Development Licensing. In addition, Gabriele Schneider has assumed the position of Vice President Business Development Services and Peter-Paul Henze has become Director Contract Manufacturing Services.
ProBioGen, which develops custom-made designer cell lines and production cell lines, is based in Berlin.
Source:
- ProBioGen press release, 29 August 2007
Copyright 2007 Evernow Publishing Ltd